Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AACR, ACS, addressed, adequacy, Amgen, ample, antitumor, arising, begun, behavior, billable, billed, bioprocessing, Biotest, bloodstream, bond, broader, BZL, chemotherapeutic, compatibility, constitute, context, contrast, correction, Corticosteroidi, creation, Cripto, currency, depletion, derecognition, Diosynth, disadvantage, distinction, disulfide, electricity, enjoyed, EORTC, error, feasibility, Global, inconclusive, integrin, Italiana, justify, largest, likelihood, modification, mortality, NCI, necessitate, opportunity, ordinary, Organisation, preparatory, prompting, pronouncement, reassessment, recaptured, recordkeeping, recurrence, reliance, replaced, residual, resolved, rollforward, routine, RTP, SAR, seasoned, sequentially, SICOR, situation, Societ, step, stimulation, substitute, tabular, thereof, thioether, threshold, translation, tubulin, twelve, unrecognized, unrecorded, Unregistered, wholly, window, yield
Removed:
activated, active, aggressive, amounted, Assistant, ATI, attaching, attack, background, belonging, bid, billion, biochem, biochemical, Biochemistry, biomedical, body, build, caution, chemically, chemotherapy, Combinatorial, combined, combining, commonly, conjugating, Connecticut, consuming, conversion, converted, cooperatively, delivered, detached, detailed, diagnostic, discovering, dividing, efficient, elicit, engineered, England, entirety, eradicated, estimating, exploiting, facilitate, feed, final, finalized, Finally, forma, generation, GlaxoSmithKline, growing, HuCAL, identifying, inactive, incomplete, innovative, intent, invested, Jen, John, joined, joining, Kellogg, lack, Lambert, led, leverage, Library, lifetime, LINKAGE, linked, London, marker, measure, Median, Medicine, minimally, necessarily, Northwestern, open, operated, originally, path, Pathology, Pauline, payload, Pennsylvania, pharmacology, Philadelphia, physiological, pilot, play, pleasure, point, powerful, pro, Professor, promise, properly, protein, pursuing, radiation, radiotherapy, range, rapid, refine, regain, register, rejoined, relapse, release, released, reliable, relinquish, represented, repurchase, repurchased, resale, resemble, residing, resistance, resurfacing, Ryan, School, Science, scientist, served, settle, shared, Shire, specificity, structured, subjective, subscription, successor, suggested, surface, Surgery, Taxol, Temple, terminating, tested, tolerable, toxic, toxicology, traded, transferable, unilaterally, University, unmet, unwanted, validate, validated, validation, vehicle, worked, written, Xenogen, Zurich
Filing tables
Filing exhibits
Related press release
IMGN similar filings
Filing view
External links
EXHIBIT 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ImmunoGen, Inc., a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended June 30, 2006 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: August 28, 2006 | /s/ Mitchel Sayare |
Mitchel Sayare | |
Chairman of the Board of Directors, Chief Executive Officer and President | |
Dated: August 28, 2006 | /s/ Daniel M. Junius |
Daniel M. Junius | |
Executive Vice President and Chief Financial Officer | |